Photo from academic.microsoft.com
Voriconazole and vincristine are major therapeutics in paediatric haematology. However, the risk‐benefit ratio of the treatment of invasive aspergillosis with voriconazole in patients receiving vincristine‐based chemotherapy remains unclear. Click to show full abstract
Voriconazole and vincristine are major therapeutics in paediatric haematology. However, the risk‐benefit ratio of the treatment of invasive aspergillosis with voriconazole in patients receiving vincristine‐based chemotherapy remains unclear.
Keywords:
aspergillosis;
refractory aspergillosis;
disorders refractory;
severe neurological;
neurological disorders;
voriconazole
Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Pharmacy and Therapeutics
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!